Select Publications
Journal articles
2024, 'Uncertainty estimation using a 3D probabilistic U-Net for segmentation with small radiotherapy clinical trial datasets', Computerized Medical Imaging and Graphics, 116, http://dx.doi.org/10.1016/j.compmedimag.2024.102403
,2024, 'Microsatellite Instability Testing and Prognostic Implications in Colorectal Cancer', Cancers, 16, http://dx.doi.org/10.3390/cancers16112005
,2024, 'p21 as a Predictor and Prognostic Indicator of Clinical Outcome in Rectal Cancer Patients', International Journal of Molecular Sciences, 25, http://dx.doi.org/10.3390/ijms25020725
,2023, 'Assessment of interfraction dose variation in pancreas SBRT using daily simulation MR images', Physical and Engineering Sciences in Medicine, 46, pp. 1619 - 1627, http://dx.doi.org/10.1007/s13246-023-01324-6
,2023, 'Changes in serial multiparametric MRI and FDG-PET/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer', European Radiology, 33, pp. 8788 - 8799, http://dx.doi.org/10.1007/s00330-023-09843-2
,2023, 'KRAS and BRAF Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient Cohort', International Journal of Molecular Sciences, 24, http://dx.doi.org/10.3390/ijms242417509
,2023, 'The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG)', International Journal of Radiation Oncology Biology Physics, 117, pp. 1096 - 1106, http://dx.doi.org/10.1016/j.ijrobp.2023.06.011
,2023, 'Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0292087
,2023, 'Mid-treatment 18F-FDG PET imaging changes in parotid gland correlates to radiation-induced xerostomia', Radiotherapy and Oncology, 186, http://dx.doi.org/10.1016/j.radonc.2023.109745
,2023, 'Prognostic and predictive values of baseline and mid-treatment FDG-PET in oropharyngeal carcinoma treated with primary definitive (chemo)radiation and impact of HPV status: Review of current literature and emerging roles', Radiotherapy and Oncology, 184, http://dx.doi.org/10.1016/j.radonc.2023.109686
,2023, 'Impact of tumour region of interest delineation method for mid-treatment FDG-PET response prediction in head and neck squamous cell carcinoma undergoing radiotherapy', Quantitative Imaging in Medicine and Surgery, 13, pp. 2822 - 2836, http://dx.doi.org/10.21037/qims-22-798
,2023, 'Prognostic Significance of MRE11 Overexpression in Colorectal Cancer Patients', Cancers, 15, http://dx.doi.org/10.3390/cancers15092438
,2023, 'Identifying the location of locoregional recurrences after definitive radiotherapy for head and neck cancer using metabolic parameters of baseline and mid-treatment 18F-FDG-PET scans', Journal of Medical Imaging and Radiation Oncology, 67, pp. 89 - 97, http://dx.doi.org/10.1111/1754-9485.13486
,2022, 'Correcting rotational error in rectal cancer radiation therapy: Can planning target volume margins be safely reduced?', Journal of Medical Radiation Sciences, 69, pp. 473 - 483, http://dx.doi.org/10.1002/jmrs.602
,2022, 'Novel methodology to quantify dehydration in head and neck cancer radiotherapy using DIXON MRI', Journal of Medical Radiation Sciences, 69, pp. 448 - 455, http://dx.doi.org/10.1002/jmrs.605
,2022, 'The delivered dose assessment in pancreas SBRT with the target position determined using an in-house position monitoring system', Frontiers in Oncology, 12, http://dx.doi.org/10.3389/fonc.2022.1009916
,2022, 'Delineation uncertainties of tumour volumes on MRI of head and neck cancer patients', Clinical and Translational Radiation Oncology, 36, pp. 121 - 126, http://dx.doi.org/10.1016/j.ctro.2022.08.005
,2022, 'Dynamic Contrast-enhanced Magnetic Resonance Imaging Evaluation of Whole Tumour Perfusion Heterogeneity Predicts Distant Disease-free Survival in Locally Advanced Rectal Cancer', Clinical Oncology, 34, pp. 561 - 570, http://dx.doi.org/10.1016/j.clon.2022.05.005
,2022, 'Prognostic Impact of TP53 Mutations and Tumor Mutational Load in Colorectal Cancer', Gastrointestinal Disorders, 4, pp. 165 - 179, http://dx.doi.org/10.3390/gidisord4030016
,2022, 'Population-level utilisation of neoadjuvant radiotherapy for the treatment of rectal cancer', Journal of Surgical Oncology, 126, pp. 322 - 329, http://dx.doi.org/10.1002/jso.26872
,2021, 'AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer', BMC Cancer, 21, http://dx.doi.org/10.1186/s12885-021-08666-y
,2021, 'Mid-treatment Fluorodeoxyglucose Positron Emission Tomography in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma Treated with Primary Radiotherapy: Nodal Metabolic Response Rate can Predict Treatment Outcomes', Clinical Oncology, 33, pp. e586 - e598, http://dx.doi.org/10.1016/j.clon.2021.07.011
,2021, 'Rectal cancer treatment and outcomes in elderly patients treated with curative intent', Molecular and Clinical Oncology, 15, http://dx.doi.org/10.3892/mco.2021.2418
,2021, 'Real world outcomes of neoadjuvant chemotherapy and radiotherapy for borderline resectable pancreatic cancer: a multicentre observational study', ANZ Journal of Surgery, 91, pp. 2447 - 2452, http://dx.doi.org/10.1111/ans.17151
,2021, 'The first real-time intrafraction target position monitoring in pancreas SBRT on an Elekta linear accelerator', Physical and Engineering Sciences in Medicine, 44, pp. 625 - 638, http://dx.doi.org/10.1007/s13246-021-01007-0
,2021, 'Quantifying and Assessing the Dosimetric Impact of Changing Gas Volumes Throughout the Course of VMAT Radiation Therapy of Upper Gastrointestinal Tumors', Advances in Radiation Oncology, 6, http://dx.doi.org/10.1016/j.adro.2021.100650
,2021, 'Multi-parametric magnetic resonance imaging assessment of whole tumour heterogeneity for chemoradiotherapy response prediction in rectal cancer', Physics and Imaging in Radiation Oncology, 18, pp. 26 - 33, http://dx.doi.org/10.1016/j.phro.2021.03.003
,2021, 'Novel 5-point 18-FDG-PET/CT visual scoring system for assessing treatment response in patients with oesophageal or gastro-oesophageal junction carcinoma', Journal of Medical Imaging and Radiation Oncology, 65, pp. 23 - 37, http://dx.doi.org/10.1111/1754-9485.13110
,2020, 'Editorial to ‘Factors affecting target motion in stereotactic body radiotherapy of liver cancer using CyberKnife’', Journal of Medical Imaging and Radiation Oncology, 64, pp. 460 - 461, http://dx.doi.org/10.1111/1754-9485.13046
,2020, 'Evaluation of the introduction of a ‘traffic light protocol’ for dose-volume histogram constraints of organs at risk in definitive radiotherapy at Liverpool and Macarthur Cancer Therapy Centres', Journal of Medical Imaging and Radiation Oncology, 64, pp. 427 - 434, http://dx.doi.org/10.1111/1754-9485.13023
,2020, 'Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT)', Practical Radiation Oncology, 10, pp. e136 - e146, http://dx.doi.org/10.1016/j.prro.2019.07.018
,2020, 'Aberrant expression of RAD52, its prognostic impact in rectal cancer and association with poor survival of patients', International Journal of Molecular Sciences, 21, http://dx.doi.org/10.3390/ijms21051768
,2019, 'Number of nodal metastases and prognosis in metastatic cutaneous squamous cell carcinoma of the head and neck', ANZ Journal of Surgery, 89, pp. 863 - 867, http://dx.doi.org/10.1111/ans.15086
,2018, 'Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis', BMC Cancer, 18, http://dx.doi.org/10.1186/s12885-018-4776-9
,2018, 'Comparison of four dimensional computed tomography and magnetic resonance imaging in abdominal radiotherapy planning', Physics and Imaging in Radiation Oncology, 7, pp. 70 - 75, http://dx.doi.org/10.1016/j.phro.2018.09.004
,2018, 'Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients', BMC Cancer, 18, http://dx.doi.org/10.1186/s12885-018-4536-x
,2018, 'An assessment of set up position for MRI scanning for the purposes of rectal cancer radiotherapy treatment planning', Journal of Medical Radiation Sciences, 65, pp. 22 - 30, http://dx.doi.org/10.1002/jmrs.266
,2017, 'Early postoperative low expression of RAD50 in rectal cancer patients associates with disease-free survival', Cancers, 9, pp. 163, http://dx.doi.org/10.3390/cancers9120163
,2017, 'Multiparametric magnetic resonance imaging in mucosal primary head and neck cancer: A prospective imaging biomarker study', BMC Cancer, 17, pp. 475, http://dx.doi.org/10.1186/s12885-017-3448-5
,2017, 'Study protocol: Multi-parametric magnetic resonance imaging for therapeutic response prediction in rectal cancer', BMC Cancer, 17, pp. 465, http://dx.doi.org/10.1186/s12885-017-3449-4
,2017, 'Nutritional status, management and clinical outcomes in patients with esophageal and gastro-oesophageal cancers: A descriptive study', Nutrition and Dietetics, 74, pp. 229 - 235, http://dx.doi.org/10.1111/1747-0080.12306
,2017, 'Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers', European Journal of Nuclear Medicine and Molecular Imaging, 44, pp. 801 - 811, http://dx.doi.org/10.1007/s00259-016-3584-1
,2017, 'A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy', Journal of Medical Imaging and Radiation Oncology, 61, pp. 99 - 123, http://dx.doi.org/10.1111/1754-9485.12496
,2017, 'Clinical significance of treatment delivery errors for helical TomoTherapy nasopharyngeal plans – A dosimetric simulation study', Physica Medica, 33, pp. 159 - 169, http://dx.doi.org/10.1016/j.ejmp.2017.01.006
,2016, 'MRE11 and ATM expression levels predict rectal cancer survival and their association with radiotherapy response', PLoS ONE, 11, http://dx.doi.org/10.1371/journal.pone.0167675
,2016, 'Prognostic utility of 18F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site', Radiotherapy and Oncology, 120, pp. 87 - 91, http://dx.doi.org/10.1016/j.radonc.2016.05.021
,2016, '18F-FDG PET-CT performed before and during radiation therapy of head and neck squamous cell carcinoma: Are they independent or complementary to each other?', Journal of Medical Imaging and Radiation Oncology, 60, pp. 433 - 440, http://dx.doi.org/10.1111/1754-9485.12439
,2016, 'Radiotherapy for pancreatic cancer', Cancer Forum, 40, pp. 43 - 46
,2016, 'Intravenous contrast-enhanced cone beam computed tomography (IVCBCT) of intrahepatic tumors and vessels', Advances in Radiation Oncology, 1, pp. 43 - 50, http://dx.doi.org/10.1016/j.adro.2016.01.001
,2016, 'Assessment of serial multi-parametric functional MRI (diffusion-weighted imaging and R2*) with (18)F-FDG-PET in patients with head and neck cancer treated with radiation therapy.', Br J Radiol, 89, pp. 20150530 - 20150530, http://dx.doi.org/10.1259/bjr.20150530
,